ArticleJournal of cellular and molecular medicine2018

Negative HBcAg in immunohistochemistry assay of liver biopsy is a predictive factor for the treatment of patients with nucleos(t)ide analogue therapy.

Mingxing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.